Evidence map›Paper›PMID 22525109›Full record

Trial reportThe Journal of adolescent health : official publication of the Society for Adolescent Medicine2012

Risk perceptions after human papillomavirus vaccination in HIV-infected adolescents and young adult women.

Jessica A Kahn, Jiahong Xu, Gregory D Zimet, Nancy Liu, René Gonin, Mary E Dillard, Kathleen Squires, Adolescent Trials Network for HIV/AIDS Interventions

Registry-linked trialAbstract readClinical Trial, Phase IIMulticenter Study
In one paragraph

Trial report in The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00710593 (Immunogenicity, Safety, Tolerability, and Behavioral Consequences of an HPV-6, -11, -16, -18 Vaccine in HIV-Infected Young Women), which is not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00710593 phase2completednot on this map

Immunogenicity, Safety, Tolerability, and Behavioral Consequences of an HPV-6, -11, -16, -18 Vaccine in HIV-Infected Young Women

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2008 to 2011Enrolled99ConditionsHIV InfectionArmsHPV vaccine for strains -6, -11, -16, and -18
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2013
    Trial
  5. Population-level sexual behaviours in adolescent girls before and after introduction of the human papillomavirus vaccine (2003-2013).CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2018
    Article
  6. Article
  7. Article
  8. Article
  9. Factors associated With Medicaid providers' recommendation of the HPV vaccine to low-income adolescent girls.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2014
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Jessica A KahnDivision of Adolescent Medicine, Cincinnati Children's Hospital Medical Center, The University of Cincinnati College of Medicine, Cincinnati, OH, USA. jessica.kahn@cchmc.org
Jiahong Xu
Gregory D Zimet
Nancy Liu
René Gonin
Mary E Dillard
Kathleen Squires
Adolescent Trials Network for HIV/AIDS Interventions
Westat (United States) · USCincinnati Children's Hospital Medical Center · USIndiana University – Purdue University Indianapolis · USSt. Jude Children's Research Hospital · USThomas Jefferson University · US

Funding

Adol. Medicine Trials Network for HIV/AIDS InterventionsU01HD040474 · NICHD · WESTAT, INC. · PI HARRIS, DONALD ROBERT · 2001 to 2016
$114.4M
LEADERSHIP GROUP FOR ADOLESCENT MEDICINE TRIALS NETWORKU01HD040533 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WILSON, CRAIG M · 2001 to 2016
$76.4M
INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARDUL1RR024134 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2006 to 2011
$70.4M
ZAP-70 EXPRESSION, CD38 EXPRESSION AND PROGNOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIAM01RR020359 · NCRR · CHILDREN'S RESEARCH INSTITUTE · PI HINDS, PAMELA S · 2005 to 2010
$13.8M
NCRR NIH HHS M01 RR020359NCRR NIH HHS M01RR020359NCRR NIH HHS UL1 RR024134NICHD NIH HHS U01 HD 040474NICHD NIH HHS U01 HD040474NICHD NIH HHS U01 HD 040533NICHD NIH HHS U01 HD040533PHS HHS NCRRUL1-RR-024134
6 · The paper itself

Abstract

purposeTo examine risk perceptions (perceived risk of human papillomavirus [HPV], perceived risk of other sexually transmitted infections [STIs], and need for safer sexual behaviors) and to determine factors associated with these risk perceptions after HPV vaccination.

methodsData were collected at the baseline visit of an HPV-6, -11, -16, -18 vaccine clinical trial in 16-23-year-old HIV-infected young women (N = 99). Immediately after receiving the first vaccine dose, participants completed a confidential questionnaire that included three 5-item scales measuring perceived risk of HPV, perceived risk of other STIs, and need for safer sexual behaviors. Linear and logistic regression models were used to examine associations between baseline characteristics (demographic characteristics; cluster of differentiation antigen 4 (CD4(+)) count; HIV viral load; knowledge about HPV and HPV vaccines; sexual behaviors; and STI diagnosis) and each measure of risk perceptions.

resultsMost participants perceived themselves to be at lower risk for HPV (mean scale score = 19.5/50), most perceived that they were not at lower risk for other STIs (mean = 31.2/50), and the vast majority reported that there was still a need for safer sexual behaviors after vaccination (mean = 43.1/50). Multivariate analyses indicated that knowledge about HPV and HPV vaccines was associated with perceived need for safer sexual behaviors (OR = 1.05, 95% CI = 1.0-1.1).

conclusionsAlthough almost all young women in this study believed that safer sexual behaviors were still important after HPV vaccination, a subset believed they were at less risk for STIs other than HPV. Educational interventions are needed to prevent misperceptions and promote healthy behaviors after vaccination.

Indexed as

Health Knowledge, Attitudes, PracticeHIV InfectionsPapillomavirus VaccinesAdolescentAdultFemaleHumansPapillomavirus InfectionsRiskSexual BehaviorSexually Transmitted DiseasesSurveys and QuestionnairesVaccinationYoung AdultPapillomavirus Vaccines

Identifiers

PMID22525109
PMCPMC3336095
OpenAlexW2039372757

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.